A Double-Edged Sword: The Anti-Cancer Effects of Emodin by Inhibiting the Redox-Protective Protein MTH1 and Augmenting ROS in NSCLC
Conclusions: Based on our data, the anti-cancer effects of emodin as an MTH1 inhibitor have clinical potential as a single agent capable of functioning as a ROS inducer and simultaneous blocker of dNTP pool sanitation in the treatment of NSCL cancers. Collectively, our results have identified for the first time that the potential molecular mechanism of emodin function, increasing DNA damage and apoptosis in cancer cells, is via MTH1 inhibition.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Divya Wahi, Deepika Soni, Abhinav Grover Tags: Research Paper Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | Lung Cancer | Non-Small Cell Lung Cancer | Study | Toxicology